Complaint Management Audit Readiness
Ensure your complaint management system withstands FDA scrutiny
Overview
What's Inside
Complaint management is one of the most frequently cited areas in FDA inspections. Investigators evaluate whether complaints are thoroughly investigated, whether root causes address material and process-related factors, and whether retain samples are tested to confirm product quality. Weak complaint systems are a direct path to 483 observations and warning letters.
This checklist is built from real FDA 483 observation patterns — including inadequate review of batch discrepancies and failures, incomplete complaint investigations that miss material or process-related causes, and failure to perform retain sample testing during complaint cases. Each section maps observations to root causes, recommended CAPA actions, and the specific evidence investigators expect to see.
It also includes an investigator-readiness section with YES/NO/N/A audit questions covering deviation management, complaint trending, QA oversight of batch disposition, and documentation standards — giving your team a practical tool to self-assess before an inspection arrives.
Why It Matters
FDA investigators specifically look for gaps in complaint investigation scope, missing trending analysis, and failure to link complaints back to batch deviations and CAPA. Incomplete complaint investigations that do not evaluate potential material or process-related causes are among the most common 483 observations — and they signal systemic quality system failures that escalate quickly.
What's Covered
Sections in this checklist
- Complaint investigation thoroughness and root cause documentation
- Material and process traceability in complaint investigations
- Retain sample testing requirements for quality-related complaints
- Batch discrepancy and deviation review prior to disposition
- Complaint trending analysis and CAPA effectiveness review
- QA oversight of investigation closure and product impact assessment
- Investigator-readiness audit questions with recommended evidence
- Root cause to CAPA mapping for common 483 observation themes
Who It's For
Target roles
Regulatory Basis
21 CFR 211.198, 21 CFR 211.192, ICH Q10, FDA Compliance Program 7356.002
Download Complaint Management Audit Readiness
Enter your details once to unlock all Audit Hub resources. All future downloads are instant.
Related Checklists
CAPA Management Audit Readiness
Audit readiness checklist for CAPA systems covering initiation timeliness, root cause analysis quality, effectiveness checks, recurrence prevention, and management review integration — built from real FDA 483 observation patterns.
Quality Risk Management Audit Readiness (ICH Q9)
Comprehensive 100-point QRM audit checklist spanning all six FDA systems plus documentation, training, complaint management, and continuous improvement — structured as Yes/No/NA self-assessment questions aligned with ICH Q9 and ICH Q10.
Document Management Audit Readiness
Comprehensive 150+ point audit checklist for pharmaceutical document management covering SOP governance, controlled document issuance, training and competency, QA oversight, data integrity and GDP compliance, retention and archiving, manufacturing and QC records, and policy governance.
Leucine is the first AI-native platform built for pharmaceutical manufacturing. It unifies quality management, regulatory compliance, and production operations into one intelligent system that powers your entire drug manufacturing lifecycle from raw materials to patient delivery.
